A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 46,949 shares of EW stock, worth $3.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
46,949
Previous 90,959 48.38%
Holding current value
$3.3 Million
Previous $8.4 Million 63.12%
% of portfolio
0.01%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$59.7 - $93.78 $2.63 Million - $4.13 Million
-44,010 Reduced 48.38%
46,949 $3.1 Million
Q2 2024

Jul 30, 2024

SELL
$84.3 - $94.31 $10.8 Million - $12.1 Million
-128,134 Reduced 58.48%
90,959 $8.4 Million
Q1 2024

May 01, 2024

BUY
$72.54 - $95.56 $284,864 - $375,264
3,927 Added 1.83%
219,093 $20.9 Million
Q4 2023

Jan 24, 2024

BUY
$61.71 - $77.76 $242,088 - $305,052
3,923 Added 1.86%
215,166 $16.4 Million
Q3 2023

Oct 26, 2023

SELL
$69.28 - $93.38 $4.64 Million - $6.26 Million
-66,991 Reduced 24.08%
211,243 $14.6 Million
Q2 2023

Aug 10, 2023

BUY
$81.41 - $94.33 $5.68 Million - $6.58 Million
69,740 Added 33.45%
278,234 $26.2 Million
Q1 2023

May 04, 2023

BUY
$74.26 - $84.51 $236,295 - $268,910
3,182 Added 1.55%
208,494 $17.2 Million
Q4 2022

Feb 09, 2023

SELL
$68.3 - $87.44 $1.49 Million - $1.91 Million
-21,857 Reduced 9.62%
205,312 $15.3 Million
Q3 2022

Nov 10, 2022

SELL
$82.37 - $107.29 $396,693 - $516,708
-4,816 Reduced 2.08%
227,169 $18.8 Million
Q2 2022

Jul 26, 2022

BUY
$86.5 - $128.27 $1.11 Million - $1.65 Million
12,862 Added 5.87%
231,985 $22 Million
Q1 2022

May 10, 2022

SELL
$101.96 - $128.34 $371,032 - $467,029
-3,639 Reduced 1.63%
219,123 $25.8 Million
Q4 2021

Feb 08, 2022

BUY
$106.37 - $130.68 $1.7 Million - $2.09 Million
15,992 Added 7.73%
222,762 $28.9 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $1.65 Million - $1.97 Million
-16,065 Reduced 7.21%
206,770 $23.4 Million
Q2 2021

Aug 11, 2021

BUY
$83.84 - $104.76 $9.56 Million - $12 Million
114,082 Added 104.9%
222,835 $23.1 Million
Q1 2021

May 13, 2021

SELL
$78.68 - $90.67 $34.9 Million - $40.2 Million
-443,449 Reduced 80.31%
108,753 $9.1 Million
Q4 2020

Feb 10, 2021

BUY
$71.69 - $91.23 $17.7 Million - $22.5 Million
246,388 Added 80.57%
552,202 $50.4 Million
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $13.6 Million - $17.7 Million
202,448 Added 195.86%
305,814 $24.4 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $3.29 Million - $4.4 Million
57,159 Added 123.7%
103,366 $7.14 Million
Q1 2020

May 12, 2020

BUY
$52.41 - $81.0 $400,307 - $618,678
7,638 Added 19.8%
46,207 $8.72 Million
Q4 2019

Feb 12, 2020

BUY
$71.7 - $82.09 $250,734 - $287,068
3,497 Added 9.97%
38,569 $9 Million
Q3 2019

Nov 12, 2019

BUY
$61.55 - $75.43 $692,068 - $848,134
11,244 Added 47.19%
35,072 $7.71 Million
Q2 2019

Aug 13, 2019

SELL
$55.74 - $64.41 $176,194 - $203,600
-3,161 Reduced 11.71%
23,828 $4.41 Million
Q1 2019

May 13, 2019

BUY
$47.89 - $64.05 $355,200 - $475,058
7,417 Added 37.9%
26,989 $5.14 Million
Q4 2018

Feb 11, 2019

SELL
$46.41 - $56.94 $9,096 - $11,160
-196 Reduced 0.99%
19,572 $3 Million
Q3 2018

Nov 13, 2018

BUY
$45.7 - $58.03 $356,094 - $452,169
7,792 Added 65.06%
19,768 $3.43 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $187,331 - $226,386
4,413 Added 58.35%
11,976 $1.75 Million
Q1 2018

May 10, 2018

BUY
$37.19 - $47.45 $46,859 - $59,787
1,260 Added 19.99%
7,563 $1.06 Million
Q4 2017

Feb 12, 2018

BUY
$33.79 - $39.39 $31,863 - $37,144
943 Added 17.59%
6,303 $712,000
Q3 2017

Nov 08, 2017

SELL
$36.29 - $38.83 $73,523 - $78,669
-2,026 Reduced 27.43%
5,360 $585,000
Q2 2017

Aug 14, 2017

BUY
N/A
7,386
7,386 $868,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $43.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.